The Institute generates news every day. Some findings are groundbreaking—some represent smaller steps. But ultimately, it is the combination of both that makes scientific advancement possible. Here is a little selection of the latest stories making it out to the wider world.
In July, Ruth Waldmann, a member of the Bavarian State Parliament for the SPD and representing the district of Upper Bavaria, visited the LIT in Regensburg, accompanied by her team. Discussions with the LIT’s Scientific Director, Prof. Philipp Beckhove, focused on scientific innovations, public funding, and the future of research in Germany.
In a recent article published in “Der Internist” (German), LIT scientists Dr. Markus Barden, Dr. Astrid Holzinger, and Prof. Hinrich Abken comprehensively review the challenges and emerging solutions for chimeric antigen receptor (CAR) T cell therapy in solid tumors. This overview is especially important for oncologists, immunologists, and medical researchers interested in cellular therapies against cancer.
Gabriele Inchingolo, Ph.D. student in Prof. Luca Gattinoni’s lab at the Leibniz Institute for Immunotherapy, has been selected as one of the winners of Bruker’s inaugural Beacon Discovery Global Grant Program.
From May 18 to June 7, 2025, Desireé Fest, apprentice in the LIT’s administration, embarked on an exciting international experience in Dublin as part of the Erasmus+ internship program. Selected by her vocational school, Desireé took part in this valuable exchange opportunity that combined professional development with cultural immersion.
The LIT Retreat took place on July 28 and 29, 2025 at Haus Bayerischer Wald in Lam.
Julia Englbrecht, a doctoral student at the Research Group “Epigenetic Immuno-oncology”, headed by Dr. Christian Schmidl, has been awarded the highly competitive doctoral scholarship by the “Studienstiftung des deutschen Volkes”.
PhD students from the Leibniz Institute for Immunotherapy (LIT) took part in the Summer School organized by the Regensburg International Graduate School of Life Sciences (RIGeL). Meghma Mukherjee has received the Best Poster Award, while Fabian Hölzl has been awarded the Best Questioner Prize. Dr. Christian Schmidl contributed as a guest lecturer at the event.
From June 27 to 29, 2025, the City of Regensburg captivated visitors at Berlin’s Wittenbergplatz with a colorful program. Prof. Philipp Beckhove, Scientific Director of the Leibniz Institute for Immunotherapy (LIT), joined Peter Aumer, member of the German Bundestag, for the ceremonial opening.
Researchers at the Leibniz Institute for Immunotherapy (LIT), together with the University Medical Center Mainz and the German Cancer Research Center, are investigating how certain immune cells—so-called Treg cells—develop into Treg cells with special healing abilities in the human immune system. To do this, they analyze the genetic fingerprint of these cells. Their findings are bringing them closer to being able to use these specialized cells for therapeutic purposes in the future.
On June 24, 2025, Dr. Harald Schwartz, a member of the Bavarian State Parliament for the CSU representing the district Amberg-Sulzbach, visited the LIT to discuss the institute’s latest research advancements and engage with the researchers.
